Fluticasone, Umeclidinium bromide, Vilanterol

Trelegy Ellipta

Powder for inhalation fluticasone furoate 100 mcg with umeclidinium 62.5 mcg and vilanterol 25 mcgNew ZealandFunded

In other countries

The same active substances on other registers, the same brand first.

Trelegy ElliptaCanada · 100 MCG / ACT + 62.5 MCG / ACT + 25 MCG / ACT · Powder · Glaxosmithkline INCSame brand
Trelegy ElliptaCanada · 200 MCG / ACT + 62.5 MCG / ACT + 25 MCG / ACT · Powder · Glaxosmithkline INCSame brand
Trelegy ElliptaEuropean Union · GlaxoSmithKline Trading Services LimitedSame brand
Trelegy® Ellipta®Serbia · 92mcg+55mcg+22mcg · prašak za inhalaciju, podeljen · Evropa Lek Pharma D.O.O. BeogradSame brand
Trelegy® Ellipta®Serbia · 92mcg+55mcg+22mcg · prašak za inhalaciju, podeljen · Evropa Lek Pharma D.O.O. BeogradSame brand
TRELEGY ELLIPTA 100/62.5/25MCG Inhalation powder, pre-dispensedSaudi Arabia · Glaxo Operations UK LtdSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Fluticasone, Umeclidinium bromide, Vilanterol

Trelegy Ellipta

Powder for inhalation fluticasone furoate 100 mcg with umeclidinium 62.5 mcg and vilanterol 25 mcgNew ZealandFunded

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Elebrato Ellipta 92 Microgramos/55 Microgramos/22 Microgramos Polvo Para Inhalacion (Unidosis)Spain · 92 µg + 55 µg + 22 µg · polvo para inhalación (unidosis) · Glaxosmithkline Trading Services Limited

Elebrato ElliptaEuropean Union · GlaxoSmithKline Trading Services Limited

Temybric ElliptaEuropean Union · GlaxoSmithKline Trading Services Limited

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

PHARMAC, New Zealand

New Zealand Pharmaceutical Management Agency (PHARMAC); https://schedule.pharmac.govt.nz/pub/schedule/archive/Schedule_2026-10.xml; October 2026; published 2026-10-08; acquired 2026-10-13T22:49:29.739475+00:00. XML-to-graph and conservative medicine-domain projections are adaptations. Written attribution; PHARMAC logo excluded.

Licence: CC BY 4.0; PHARMAC Pharmaceutical Schedule XML files · Added 14 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Fluticasone, Umeclidinium bromide, Vilanterol
Dosage form: Powder for inhalation fluticasone furoate 100 mcg with umeclidinium 62.5 mcg and vilanterol 25 mcg
Register: New Zealand (PHARMAC)
Status: Funded
Status in the register: Funded by PHARMAC
Procedure: Community Pharmaceutical Schedule
Supply: Funded (PHARMAC)